China Shineway Pharmaceutical Group Limited announced that the English and Chinese versions of its 2025 Annual Report, the circular and notice of the upcoming Annual General Meeting (AGM), and the associated proxy form have been published. All documents are available on both the company’s website (www.shineway.com.hk) and HKEXnews (www.hkexnews.hk).

The notification, dated 24 April 2026, also confirms the simultaneous release of the group’s 2025 Environmental, Social and Governance (ESG) Report, likewise accessible through the same online platforms under the “Investor Relations” section.

Non-registered shareholders who prefer electronic delivery of future corporate communications are instructed to provide a functional email address via their designated intermediaries—banks, brokers, custodians, nominees or HKSCC Nominees Limited. Until an email address is recorded, shareholders will not receive digital alerts and must independently check the two websites for updates.

Those wishing to obtain printed copies of the current or future documents should submit a written request at least 10 days in advance to the company’s Hong Kong share registrar, Computershare Hong Kong Investor Services Limited (17M Floor, Hopewell Centre, 183 Queen’s Road East, Wan Chai, Hong Kong), email ChinaShineway.ecom@computershare.com.hk, or call +852 2862 8555 during business hours.

Company Secretary Lee Bun Ching Terence signed the notice on behalf of China Shineway Pharmaceutical Group Limited.